Earlier Disclosure of Blood-Based Biomarkers Enhances Diagnostic Certainty and Clinical Management in Cognitive Disorders: A Review of a Recent Randomized Clinical Trial
Posted inClinical Updates Neurology news Pathology & Lab Medicine

Earlier Disclosure of Blood-Based Biomarkers Enhances Diagnostic Certainty and Clinical Management in Cognitive Disorders: A Review of a Recent Randomized Clinical Trial

Early disclosure of plasma p-tau217 and NfL biomarkers significantly improves diagnostic confidence and clinical decisions in cognitive decline without increasing emotional distress, supporting their integration into routine memory clinic care.
Impact of Clonal Hematopoiesis and Pre-treatment Neutropenia on CAR-T Cell Therapy Outcomes in Hematological Malignancies
Posted inHematology-Oncology news Oncology

Impact of Clonal Hematopoiesis and Pre-treatment Neutropenia on CAR-T Cell Therapy Outcomes in Hematological Malignancies

This study evaluates how clonal hematopoiesis of indeterminate potential (CHIP) and pre-treatment neutropenia affect clinical outcomes and toxicities in patients undergoing CAR-T therapy for hematologic cancers, revealing nuanced risks for specific toxicities without compromising survival outcomes.
Telehealth Cognitive Behavioral Therapy for Anxiety in Emergency Department Patients with Low-Risk Chest Pain: Insights from the PACER Randomized Clinical Trial
Posted inEmergency Medicine news Psychiatry

Telehealth Cognitive Behavioral Therapy for Anxiety in Emergency Department Patients with Low-Risk Chest Pain: Insights from the PACER Randomized Clinical Trial

The PACER trial demonstrates that peer-supported internet-based CBT significantly reduces anxiety in ED patients with low-risk chest pain, with pronounced benefits in severe anxiety cases, supporting telehealth CBT as an effective anxiety treatment adjunct post-ED discharge.
Outcomes of Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Young Adults: Insights from the EBMT Chronic Malignancies Working Party
Posted inHematology-Oncology news

Outcomes of Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Young Adults: Insights from the EBMT Chronic Malignancies Working Party

This retrospective study evaluates survival outcomes and risk factors associated with allogeneic hematopoietic cell transplantation in young adults (18-40 years) with myelodysplastic syndrome, revealing encouraging survival rates and highlighting critical prognostic variables for personalized transplant strategies.
CD25-based Graft-versus-Host Disease Prophylaxis after Haploidentical Hematopoietic Stem Cell Transplantation: Comparative Analysis of Two Prophylactic Regimens
Posted inClinical Updates Hematology-Oncology news

CD25-based Graft-versus-Host Disease Prophylaxis after Haploidentical Hematopoietic Stem Cell Transplantation: Comparative Analysis of Two Prophylactic Regimens

This review synthesizes emerging evidence comparing high-dose anti-CD25 (without methotrexate) versus low-dose anti-CD25 (with methotrexate) strategies for GVHD prophylaxis in haplo-HSCT, highlighting improved acute GVHD control and GRFS with the former approach.